Hand eczema and health-related quality of life; A comparison of EQ-5D and the Dermatology Life Quality Index (DLQI) in relation to the hand eczema extent score (HEES)

Contact Dermatitis

Volumn 69, Issue 3, 2013, Pages 138-143

  Lindberg, Magnus ^a,b   Bingefors, Kerstin ^c   Meding, Birgitta ^d   Berg, Mats ^c,e  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Center for Clinical Research Sormland   (Sweden)

Author keywords

DLQI; EQ 5D; hand eczema; HEES; quality of life

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DERMATOLOGY LIFE QUALITY INDEX; FACTORIAL ANALYSIS; FEMALE; HAND ECZEMA; HAND ECZEMA EXTENT SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; QUALITY OF LIFE; SCORING SYSTEM; SEX DIFFERENCE;

DLQI; EQ-5D; HAND ECZEMA; HEES; QUALITY OF LIFE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ECZEMA; FEMALE; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84882370082     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12067     Document Type: Article

References (37)

1. Stenberg B, Meding B, Svensson A,. Dermatology in public health-a model for surveillance of common skin diseases. Scand J Public Health 2010: 38: 368-374.
2. Thyssen J P, Johansen J D, Linneberg A, Menneá T,. The epidemiology of hand eczema in the general population-prevalence and main findings. Contact Dermatitis 2010: 62: 75-87.
3. Meding B, Järvholm B,. Hand eczema in Swedish adults-changes in prevalence between 1983 and 1996. J Invest Dermatol 2002: 118: 719-723.
4. Meding B, Wrangsjö K, Järvholm B,. Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005: 152: 975-980.
5. Meding B, Swanbeck G,. Consequences of having hand eczema. Contact Dermatitis 1990: 23: 6-14.
6. Cvetkovski R S, Rothman K J, Olsen J, Mathiesen B, Iversen L, Johansen J D, Agner T,. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005: 152: 93-98.
7. Meding B, Lantto R, Lindahl G, Wrangsjö K, Bengtsson B,. Occupational skin disease in Sweden-a 12-year follow-up. Contact Dermatitis 2005: 53: 308-313.
8. Mälkönen T, Alanko K, Jolanki R, Luukkonen R, Aalto-Korte K, Laurema A, Susitaival P,. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010: 163: 999-1006.
9. Vein N K, Hattel T, Laurberg G,. Hand eczema: causes, course, and prognosis II. Contact Dermatitis 2008: 58: 335-339.
10. Lerbaek A, Kyvik K O, Ravn H, Menné T, Agner T,. Clinical characteristics and consequences of hand eczema-an 8-year follow-up study of a population-based twin cohort. Contact Dermatitis 2008: 58: 210-216.
11. Cvetkovski R S, Zachariae R, Jensen H, Olsen J, Johansen J D, Agner T,. Prognosis of occupational hand eczema: a follow-up study. Arch Dermatol 2006: 142: 305-311.
12. Hald M, Agner T, Blands J, et al. Clinical severity and prognosis of hand eczema. Br J Dermatol 2009: 160: 1229-1236.
13. Agner T, Andersen K E, Brandao F M, et al. EECDRG. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis 2008: 59: 43-47.
14. Wallenhammar L M, Nyfjäll M, Lindberg M, Meding B,. Health-related quality of life and hand eczema-a comparison of two instruments, including factor analysis. J Invest Dermatol 2004: 122: 1381-1389.
15. Cvetkovski R S, Zachariae R, Jensen H, Olsen J, Johansen J D, Agner T,. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006: 54: 106-111.
16. Skoet R, Zachariae R, Agner T,. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol 2003: 149: 452-456.
17. Agner T, Andersen K E, Brandão F M, et al. EECDRG. Contact sensitisation in hand eczema patients-relation to subdiagnosis, severity and quality of life: a multi-centre study. Contact Dermatitis 2009: 61: 291-296.
18. Weistenhofer W, Baumeister T, Drexler H, Kutting B,. How to quantify skin impairment in primary and secondary prevention? HEROS: a proposal of a hand eczema score for occupational screenings. Br J Dermatol 2011: 164: 807-813.
19. Moberg C, Alderling M, Meding B,. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009: 161: 397-403.
20. Bingefors K, Lindberg M, Isacson D,. Quality of life, use of topical medications and socio-economic data in hand eczema: a Swedish nationwide survey. Acta Derm Venereol 2011: 91: 452-458.
21. Basra M K, Fenech R, Gatt R M, Salek M S, Finlay A Y,. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008: 159: 997-1035.
22. Ware J, Sherbourne C,. The MOS 36 item short form health survey (SF-36). Med Care 1992: 30: 473-483.
23. Ware J, Kosinski M, Sherbourne C,. SF-36 Physical and Mental Health Summary Scales: a User's Manual: Boston, MA, New England Medical Center, 1994.
24. Ware J, Snow K, Kosinski M, Sherbourne C,. SF-36 Health Survey Manual and Interpretation Guide: Boston, MA, New England Medical Center, 1993.
25. Rabin R, de Charro F,. A measure of health status from the EuroQol Group. Ann Med 2001: 33: 337-343.
26. Weistenhofer W, Baumeister T, Drexler H, Kutting B,. An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence-based medicine. Br J Dermatol 2010: 162: 239-250.
27. Meding B, Swanbeck G,. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol 1989: 69: 227-233.
28. Carlsson A, Gånemo A, Anderson C D, Meding B, Stenberg B, Svensson Å,. Scoring of hand eczema: good agreement between patients and dermatological staff. Br J Dermatol 2011: 165: 123-128.
29. Stenberg B, Lindberg M, Meding B, Svensson Å,. Is the question 'Have you had childhood eczema?' useful for assessing childhood atopic eczema in adult population surveys? Contact Dermatitis 2006: 54: 334-337.
30. Finlay A Y, Khan G K,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994: 19: 210-216.
31. Burström K, Johannesson M, Didrichsen F,. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001: 10: 621-635.
32. Dolan P,. Modeling valuations for EuroQol health states. Med Care 1997: 35: 1095-1108.
33. Norlin J M, Steen Carlsson K, Persson U, Schmitt-Egenolf M,. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients. Br J Dermatol 2012: 166: 797-802.
34. Lindberg M, Berg M,. Some observations on reporting quality of life in treatment of psoriasis in outpatient clinics. Acta Derm Venereol 2013: 93: 210-211.
35. Dorman P J, Dennis M, Sandercock P,. How do scores on the EuroQol relate to to the scores on the SF-36 after stroke? Stroke 1999: 30: 2146-2151.
36. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M,. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000: 80: 430-434.
37. Meding B, Wrangsjö K, Järvholm B,. Hand eczema extent and morphology-association and influence on long-term prognosis. J Invest Dermatol 2007: 127: 2147-2151.